Bone Substitute Portfolio
8Pages

Bone Substitute Portfolio

Company Overview • JRI Limited, established in 1970 by Mr Ronald Furlong, FRCS • First H-AC coated hip replacement in the world – Furlong® H-AC 9th September 1985 • Market leading peer reviewed clinical results • Dedicated orthopaedic research, development and manufacture • Wholly owned by the Furlong Research Charitable Foundation who independently fund orthopaedic r

Bone Substitute Portfolio Mnldible Bono Substitute Preformed Bone Substitute FtEnlble Bone Substitute

Bone Substitute Portfolio: SINTLIFE Mg-hydroxyapatite Paste & Putty REVISION SURGERY CAVITY DEFECTS SMALL JOINTS SINTLIFE Biomimetic Mg-hydroxyapatite in microgranules or paste/putty form Code Nanostructured Paste (syringe) Nanostructured Paste (syringe) Nanostructured Putty (syringe) Nanostructured Putty (syringe) Nanostructured Putty (syringe) Nanostructured Putty (syringe)

Flexible Bore Substitute

ENGIPORE High porosity hydroxyapatite small defects large defects REVISION SURGERY CAVITY DEFECTS SMALL JOINTS ENGIPORE (High porosity Hydroxyapatite-based chips and 3D forms) Code Wedge (dimension 40x30 mm incl. 11°) Wedge (dimension 40x30 mm incl. 15°) Wedge (dimension 40x30 mm incl. 19°) Wedge (dimension 30x15 mm incl. 11° ) Wedge (dimension 30x15 mm incl. 15° ) Wedge (dimension 30x15 mm incl. 9° )

REPROS 60% Hydroxyapatite 40% beta-tricalciumphosphate small defects large defects REVISION SURGERY CAVITY DEFECTS SMALL JOINTS REPROS Hydroxyapatite/ beta-tricalciumphosphate Granules Code Granules (size 1.0-4.0mm) non-resorbable Granules (size 1.0-4.0mm) non-resorbable Hydroxyapatite/ beta-tricalciumphosphate Blocks 510.05.05

18 Churchill Way, 35A Business Park, Chapeltown, Sheffield S35 2PY